Peri-implant Disease and Prosthetic Cement: Cross-sectional Study
- Disease/Condition
- Peri-implant Mucositis,Peri-Implantitis
- Study type
- Observational
- Primary sponsor
- University of Bologna
- Location
- Bologna, Italy
- Phase
- N/A
- Start date
- Oct 29, 2018
- End date
- Jul 19, 2019
- Enrollment
- 46 participants
Prevalence of submucosal cement
The main objective of the present clinical study project, of a cross-sectional observational
 nature, is to evaluate the presence of submucosal cement residues through endoscopic
 visualization in clinical situations with peri-implant disease.
 
 The secondary objective is to investigate the potential correlation between the severity of
 the pathological condition and the spatial position of cement residues in relation to the
 implant-prosthetic unit.
 
 For each subject, the following data were collected: gender, age, periodontal history,
 smoking habits, reasons for implant rehabilitation (trauma, caries, periodontitis, agenesis,
 other), the position of the implant in the oral cavity, elapsed time between prosthetic
 rehabilitation and pathological condition. If the deposit was recognized as cement residue,
 its presence was recorded, and the anatomical position of the cement residue (mesial, distal,
 lingual/palatal, vestibular) and the spatial position of cement residues in relation to the
 implant-prosthetic unit were collected.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT05945836
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT05945836 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Bologna and is currently Completed. The study focuses on Peri-implant Mucositis,Peri-Implantitis. Target enrollment is 46 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.